Colchicine should not be used in the management of COVID-19 within primary care, other than in the context of a trial. Use in licensed indications remains unaffected.
Subject to regulatory approval, agreement has been reached to add colchicine to the PRINCIPLE trial. Practices are encouraged to continue to support recruitment to this important UK platform trial, which is evaluating potential COVID-19 therapies in primary care.